Gregory Richard J.
Executive VP & CSO at ImmunoGen, Inc.
- Sold, on record
- $642k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jan 7, 2019
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- ImmunoGen, Inc.Executive VP & CSO
Sales by reason
0
Routine
5
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Jan 7, 2019Plan not stated
Sold 1.3% of their holdings
$16k3,038 shares at $5.27
- Feb 22, 2018Plan not stated
Sold 15.5% of their holdings
$205k36,643 shares at $5.60
- Feb 21, 2018Plan not stated
Sold 12.6% of their holdings
$375k34,486 shares at $10.88
- Jan 8, 2017Plan not stated
Sold 1.1% of their holdings
$19k2,904 shares at $6.64
- Jan 8, 2016Plan not stated
Sold 9.5% of their holdings
$26k2,369 shares at $11.10
5 of 5
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | Jun 17, 2022 | QTTB | Director | AwardedOption (Right to Buy) | 18,000 | 18,000 | SEC | ||
| Jun 17, 2021 | Jun 22, 2021 | QTTB | Director | AwardedOption (Right to Buy) | 18,000 | 18,000 | SEC | ||
| Jun 10, 2020 | Jun 12, 2020 | QTTB | Director | AwardedOption (Right to Buy) | 18,000 | 18,000 | SEC | ||
| Nov 18, 2019 | Jan 29, 2020 | QTTB | Director | Exercised or settledEmployee Stock Option | 10,806 | 0 | SEC | ||
| Nov 18, 2019 | Jan 29, 2020 | QTTB | Director | Exercised options | 10,806 | $0.0300 | $324 | 10,806 | SEC |
| Jun 6, 2019 | Jun 10, 2019 | QTTB | Director | AwardedOption (Right to Buy) | 15,580 | 15,580 | SEC | ||
| Jan 31, 2019 | Feb 4, 2019 | ImmunoGen, Inc. | Executive VP & CSO | AwardedStock option (right to buy) | 289,150 | $5.25 | $1.5M | 289,150 | SEC |
| Jan 7, 2019 | Jan 8, 2019 | ImmunoGen, Inc. | Executive VP & CSO | Sold | 3,038 | $5.27 | $16k | 236,056 | SEC |
| Mar 27, 2018 | Mar 29, 2018 | QTTB | Director | AwardedEmployee stock option | 31,160 | 31,160 | SEC | ||
| Feb 22, 2018 | Feb 25, 2019 | ImmunoGen, Inc. | Executive VP & CSO | Sold | 36,643 | $5.60 | $205k | 199,413 | SEC |
| Feb 21, 2018 | Feb 23, 2018 | ImmunoGen, Inc. | Executive VP & CSO | Sold | 34,486 | $10.88 | $375k | 239,094 | SEC |
| Feb 15, 2018 | Feb 20, 2018 | ImmunoGen, Inc. | Executive VP & CSO | AwardedStock option (right to buy) | 256,500 | $10.65 | $2.7M | 256,500 | SEC |
| Feb 21, 2017 | Feb 23, 2017 | ImmunoGen, Inc. | Executive VP & CSO | Awarded | 237,250 | $2.47 | $586k | 276,481 | SEC |
| Jan 8, 2017 | Jan 8, 2018 | ImmunoGen, Inc. | Executive VP & CSO | Sold | 2,904 | $6.64 | $19k | 273,577 | SEC |
| Nov 2, 2016 | Nov 3, 2016 | ImmunoGen, Inc. | Executive VP & CSO | Bought | 16,600 | $1.78 | $30k | 39,231 | SEC |
| Jul 18, 2016 | Jul 20, 2016 | ImmunoGen, Inc. | Executive VP & CSO | AwardedStock option (right to buy) | 110,000 | $3.05 | $336k | 110,000 | SEC |
| Jan 8, 2016 | Jan 11, 2016 | ImmunoGen, Inc. | Executive VP & CSO | Sold | 2,369 | $11.10 | $26k | 22,631 | SEC |
| Jul 13, 2015 | Jul 14, 2015 | ImmunoGen, Inc. | Executive VP & CSO | AwardedStock option (right to buy) | 50,000 | $16.72 | $836k | 50,000 | SEC |
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2019 | Jan 8, 2019 | ImmunoGen, Inc. | Executive VP & CSO | Form 4 sale | 3,038 | $16k | 1.3% | Plan not stated | SEC |
| Feb 22, 2018 | Feb 25, 2019 | ImmunoGen, Inc. | Executive VP & CSO | Form 4 sale | 36,643 | $205k | 15.5% | Plan not stated | SEC |
| Feb 21, 2018 | Feb 23, 2018 | ImmunoGen, Inc. | Executive VP & CSO | Form 4 sale | 34,486 | $375k | 12.6% | Plan not stated | SEC |
| Jan 8, 2017 | Jan 8, 2018 | ImmunoGen, Inc. | Executive VP & CSO | Form 4 sale | 2,904 | $19k | 1.1% | Plan not stated | SEC |
| Jan 8, 2016 | Jan 11, 2016 | ImmunoGen, Inc. | Executive VP & CSO | Form 4 sale | 2,369 | $26k | 9.5% | Plan not stated | SEC |